Currently out of the existing stock ratings of Laura Chico, 353 are a BUY (72.34%), 123 are a HOLD (25.2%), 12 are a SELL (2.46%).

Laura Chico

Work Performance Price Targets & Ratings Chart

Analyst Laura Chico, currently employed at WEDBUSH, carries an average stock price target met ratio of 52.09% that have a potential upside of 34.39% achieved within 212 days.

Laura Chico’s has documented 960 price targets and ratings displayed on 53 stocks. The coverage is on Healthcare, Industrials, Consumer Cyclical sectors.

Most recent stock forecast was given on GOSS, Gossamer Bio.

Wall Street Analyst Laura Chico

Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for DNLI (DENALI THERAPEUTICS) at 11/10/2020. The price target of $64 was fulfilled within 1 day with a profit of $4 (6.67%) receiving and performance score of 66.67.

Average potential price target upside

of $41.26 (35.62%) on KRTX (KARUNA THERAPEUTICS).
of $33.58 (30.14%) on ALXN (ALEXION PHARMACEUTICALS).
of $24.52 (217.86%) on SA (SEABRIDGE GOLD).

ACER Acer Therapeutics ALXN Alexion Pharmaceuticals APLS Apellis Pharmaceuticals APTX Aptinyx ARDX Ardelyx BHVN Biohaven Pharmaceutical Holding Co Ltd BIIB Biogen DNLI Denali Therapeutics KRTX Karuna Therapeutics NBIX Neurocrine Biosciences PRAX Praxis Precision Medicines RARE Ultragenyx RTRX Travere Therapeutics SAGE Sage Therapeutic TSHA Taysha Gene Therapies TVTX Travere Therapeutics VIE Viela Bio XENE Xenon Pharmaceuticals PRVL Prevail Therapeutics VYGR Voyager Therapeutics DSGN Design Therapeutics IMPL Impel Neuropharma VERA Vera Therapeutics STOK Stoke Therapeutics DOVA Dova Pharmaceuticals MLND Millendo Therapeutics PEPG PepGen Ltd VIGL Vigil Neuroscience VRTX Vertex Pharmaceuticals ATXS Astria Therapeutics PASG Passage Bio BMRN Biomarin Pharmaceutical EWTX Edgewise Therapeutics KDNY Chinook Therapeutics LBPH Longboard Pharmaceuticals PHVS Pharvaris BV RLYB Rallybio Corp VRDN Viridian Therapeutics AVTE Aerovate Therapeutics GOSS Gossamer Bio ANRO Alto Neuroscience DNTH Dianthus Therapeutics LRMR Larimar Therapeutics OVID Ovid Therapeutics SLDB Solid Biosciences LLC BCRX BioCryst Pharmaceuticals DOV Dover KD Kyndryl Holdings LB L Brands SA Seabridge Gold TRML Tourmaline Bio CRBP Corbus Pharmaceuticals LEN Lennar

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jonathan Aschoff (ROTH MKM)

Hold

$1.5

$0.84 (127.27%)

$10

3 years 2 months 11 days ago
(01-Sep-2023)

0/3 (0%)

$0.36 (31.58%)

Please subscribe to see extended stock data

Constantine Davides (JMP)

Buy

$7.34 (1112.12%)

4 years 8 months 5 days ago
(07-Mar-2022)

0/2 (0%)

$5.54 (225.20%)

Please subscribe to see extended stock data

Laura Chico (WEDBUSH)

Buy

$7.34 (1112.12%)

$48

7 years 4 months 18 days ago
(25-Jun-2019)

0/4 (0%)

$3.88 (94.17%)

Please subscribe to see extended stock data

Vernon Bernardino (HC WAINWRIGHT)

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Laura Chico most bullish on?

Potential upside of $35.97 has been obtained for DNTH (DIANTHUS THERAPEUTICS)

Which stock is Laura Chico most reserved on?

Potential downside of -$148.59 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

What Year was the first public recommendation made by Laura Chico?

On 2015